The Economic Times is tracking live market updates for Sun Pharmaceutical Industries Ltd. (Sun Pharma) on August 31, 2026, in a rolling coverage of the company's share price and trading activity.

The live blog's coverage includes the following areas of Sun Pharma's market performance:

• Daily performance update and market activity: Ongoing tracking of Sun Pharma's price movement and overall market activity for the session.
• Technical breakout: Sun Pharma's stock broke above its 20-day simple moving average (SMA), a technical development noted in the live coverage. The 20-day SMA is a commonly used short-term trend indicator; when a stock crosses above it, traders typically read that as a sign of strengthening near-term momentum, though such signals are descriptive rather than predictive.
• 3-month performance: The update reviews the stock's performance over the past three months.
• Beta: Sun Pharma's beta reflects what the live blog describes as consistent market behavior. Beta is a measure of a stock's volatility relative to the broader market; a beta near 1 indicates price movements broadly in line with the overall index, while values below 1 suggest comparatively lower volatility.
• Previous day close and trading volume: The live updates include Sun Pharma's previous trading day closing price and a snapshot of its trading volume.

Sun Pharma is one of India's largest pharmaceutical companies and a heavily traded constituent of Indian equity benchmarks, which is why its intraday share price movements are covered in live-market tracking formats. The company is a major player in generics, specialty pharmaceuticals, and active pharmaceutical ingredients, and its stock is closely watched as a bellwether for India's pharma sector, one of the country's largest export-oriented industries.

Readers following the technical breakout may want to watch subsequent sessions to see whether the stock sustains its position above the 20-day SMA, alongside the volume data and broader market activity included in the live coverage.

Readers can follow the full rolling coverage, including stock details and technical indicators, on The Economic Times live blog.